Baker Tilly Wealth Management, LLC Novo Nordisk A S Transaction History

Baker Tilly Wealth Management, LLC

$220 Million
Q3 2024

A detailed history of Baker Tilly Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 10,318 shares of NVO stock, worth $1.11 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

10,318

Previous 13,191 21.78%

Holding current value

$1.11 Million

Previous $1.88 Million 34.75%

% of portfolio

0.56%

Previous 0.79%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$119.07 - $145.42 $342,088 - $417,791	-2,873 Reduced 21.78%	10,318 $1.23 Million
Q2 2024 Jul 18, 2024	SELL	$122.71 - $146.91 $3.28 Million - $3.92 Million	-26,716 Reduced 66.95%	13,191 $1.88 Million
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $145,813 - $194,093	-1,428 Reduced 3.45%	39,907 $5.12 Million
Q4 2023 Jan 10, 2024	SELL	$87.78 - $105.45 $270,450 - $324,891	-3,081 Reduced 6.94%	41,335 $4.28 Million
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $1.42 Million - $3.11 Million	15,586 Added 54.06%	44,416 $4.04 Million
Q2 2023 Jul 20, 2023	BUY	$155.98 - $172.65 $93,588 - $103,590	600 Added 2.13%	28,830 $4.67 Million
Q1 2023 Apr 12, 2023	SELL	$132.34 - $159.14 $884,825 - $1.06 Million	-6,686 Reduced 19.15%	28,230 $4.49 Million
Q4 2022 Jan 26, 2023	BUY	$102.55 - $135.33 $289,191 - $381,630	2,820 Added 8.79%	34,916 $0
Q3 2022 Oct 20, 2022	SELL	$95.28 - $116.93 $39,445 - $48,409	-414 Reduced 1.27%	32,096 $3.2 Million
Q2 2022 Jul 28, 2022	SELL	$103.24 - $121.81 $37,785 - $44,582	-366 Reduced 1.11%	32,510 $3.62 Million
Q1 2022 Apr 27, 2022	BUY	$93.1 - $112.54 $174,469 - $210,899	1,874 Added 6.04%	32,876 $3.65 Million
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $395,696 - $483,189	4,127 Added 15.36%	31,002 $3.47 Million
Q3 2021 Nov 02, 2021	BUY	$84.42 - $106.62 $9,961 - $12,581	118 Added 0.44%	26,875 $2.58 Million
Q2 2021 Jul 30, 2021	BUY	$67.66 - $84.76 $155,956 - $195,371	2,305 Added 9.43%	26,757 $2.24 Million
Q1 2021 Apr 28, 2021	BUY	$67.06 - $75.82 $433,744 - $490,403	6,468 Added 35.97%	24,452 $1.65 Million
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $1.15 Million - $1.33 Million	17,984 New	17,984 $1.26 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Account

Baker Tilly Wealth Management, LLC Novo Nordisk A S Transaction History